- By insider
Chair, President & CEO of Catalent Inc (CTLT) John R Chiminski sold 130,545 shares of CTLT on 10/01/2018 at an average price of $45.32 a share. The total sale was $5.9 million.
Catalent Inc is a drug development, delivery and supply partner company. It engages in advanced delivery technologies and development solutions for drugs, biologics, and consumer health products across US, Europe and other international markets. Catalent Inc has a market cap of $6.73 billion; its shares were traded at around $46.34 with a P/E ratio of 73.58 and P/S ratio of 2.51.
-
Warning! GuruFocus has detected 4 Warning Signs with CTLT. Click here to check it out.
-
The intrinsic value of CTLT
CEO Recent Trades:
-
Chair, President & CEO John R Chiminski sold 130,545 shares of CTLT stock on 10/01/2018 at the average price of $45.32. The price of the stock has increased by 2.25% since.
Directors and Officers Recent Trades:
-
Director Donald E Jr Morel bought 10,000 shares of CTLT stock on 09/13/2018 at the average price of $43. The price of the stock has increased by 7.77% since.
For the complete insider trading history of CTLT, click here
.This article first appeared on GuruFocus.
-
Warning! GuruFocus has detected 4 Warning Signs with CTLT. Click here to check it out.
-
The intrinsic value of CTLT